Q53RT3
Gene name |
ASPRV1 |
Protein name |
Retroviral-like aspartic protease 1 |
Names |
Skin-specific retroviral-like aspartic protease, SASPase, Skin aspartic protease, TPA-inducible aspartic proteinase-like protein, TAPS |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:151516 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q53RT3
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q53RT3-F1 | Predicted | AlphaFoldDB |
4 variants for Q53RT3
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| VAR_084554 | 199 | K>E | ADLI; impairs filaggrin cleavage [UniProt] | Yes | UniProt |
| VAR_084555 | 311 | R>P | ADLI; impairs filaggrin cleavage [UniProt] | Yes | UniProt |
| VAR_084556 | 314 | P>T | ADLI; impairs filaggrin cleavage [UniProt] | Yes | UniProt |
|
VAR_051508 rs3796097 |
49 | T>A | No |
UniProt dbSNP |
1 associated diseases with Q53RT3
[MIM: 146750]: Ichthyosis, lamellar, autosomal dominant (ADLI)
An autosomal dominant form of ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling. ADLI is characterized by onset at birth or within the first months of life, skin scaling on the entire body with relative sparing of face, anterior chest, and abdomen, and palmoplantar keratoderma. Patients may manifest mild erythema and moderate pruritus. {ECO:0000269|PubMed:32516568}. Note=The disease is caused by variants affecting the gene represented in this entry.
Without disease ID
- An autosomal dominant form of ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling. ADLI is characterized by onset at birth or within the first months of life, skin scaling on the entire body with relative sparing of face, anterior chest, and abdomen, and palmoplantar keratoderma. Patients may manifest mild erythema and moderate pruritus. {ECO:0000269|PubMed:32516568}. Note=The disease is caused by variants affecting the gene represented in this entry.
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| aspartic-type endopeptidase activity | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which a water molecule bound by the side chains of aspartic residues at the active center acts as a nucleophile. |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| protein processing | Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein. |
| skin development | The process whose specific outcome is the progression of the skin over time, from its formation to the mature structure. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner vascular dermis (cutis, corium or true skin) composed mostly of connective tissue. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MGSPGASLGI | KKALQSEQAT | ALPASAPAVS | QPTAPAPSCL | PKAGQVIPTL | LREAPFSSVI |
| 70 | 80 | 90 | 100 | 110 | 120 |
| APTLLCGFLF | LAWVAAEVPE | ESSRMAGSGA | RSEEGRRQHA | FVPEPFDGAN | VVPNLWLHSF |
| 130 | 140 | 150 | 160 | 170 | 180 |
| EVINDLNHWD | HITKLRFLKE | SLRGEALGVY | NRLSPQDQGD | YGTVKEALLK | AFGVPGAAPS |
| 190 | 200 | 210 | 220 | 230 | 240 |
| HLPKEIVFAN | SMGKGYYLKG | KIGKVPVRFL | VDSGAQVSVV | HPNLWEEVTD | GDLDTLQPFE |
| 250 | 260 | 270 | 280 | 290 | 300 |
| NVVKVANGAE | MKILGVWDTA | VSLGKLKLKA | QFLVANASAE | EAIIGTDVLQ | DHNAILDFEH |
| 310 | 320 | 330 | 340 | ||
| RTCTLKGKKF | RLLPVGGSLE | DEFDLELIEE | DPSSEEGRQE | LSH |